Showing results (101-110 of 424) with videos related to

Sort By:
Pageof 43
Expert Review of Gastroenterology & Hepatology|April 12, 2011
Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?Amedeo Lonardo, Stefano Bellentani, Vlad Ratziu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 19, 2006
Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis groupJohn McHutchison, Thierry Poynard, Nezam Afdhal, et al.
Gastroenterologie Clinique Et Biologique|December 17, 2008
FibroTest-ActiTest as a non-invasive marker of liver fibrosisPhilippe Halfon, Mona Munteanu, Thierry Poynard
Journal of Hepatology|February 15, 2003
A comparison of fibrosis progression in chronic liver diseasesThierry Poynard, Philippe Mathurin, Ching-Lung Lai, et al.
Journal of Hepatology|April 4, 2006
The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver diseaseDominique Thabut, Sylvie Naveau, Frederic Charlotte, et al.
Gastro Hep Advances|August 12, 2024
External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis BThierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplantsRaluca Pais, Pascal Lebray, Geraldine Rousseau, et al.
JHEP Reports : Innovation in Hepatology|June 18, 2021
External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCVThierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, et al.
BMC Gastroenterology|October 17, 2007
Meta-analyses of FibroTest diagnostic value in chronic liver diseaseThierry Poynard, Rachel Morra, Philippe Halfon, et al.
European Journal of Gastroenterology & Hepatology|December 3, 2019
Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetesThierry Poynard, Valentina Peta, Olivier Deckmyn, et al.
Pageof 43